Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results Appointed director
|
CRH Medical Corp (CRHM)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/28/2021 |
8-K
| Quarterly results |
04/20/2021 |
8-K
| Quarterly results |
04/06/2021 |
8-K
| Quarterly results |
04/05/2021 |
8-K
| Quarterly results |
04/01/2021 |
8-K
| Quarterly results |
03/23/2021 |
8-K
| Quarterly results |
03/16/2021 |
8-K
| Quarterly results |
03/11/2021 |
8-K
| Quarterly results |
02/23/2021 |
8-K
| Quarterly results |
02/09/2021 |
8-K
| Quarterly results |
02/08/2021 |
8-K
| Quarterly results |
01/06/2021 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
12/23/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data
Docs:
|
"SECURITIES AND EXCHANGE COMMISSION",
"About CRH Medical Corporation: CRH Medical Corporation is a North American company focused on providing gastroenterologists throughout the United States with innovative services and products for the treatment of gastrointestinal diseases. In 2014, CRH became a full-service gastroenterology anesthesia company that provides anesthesia services for patients undergoing endoscopic procedures in ambulatory surgical centers. To date, CRH has completed 31 anesthesia acquisitions, and now serves 68 ambulatory surgical centers in 13 states. In addition, CRH owns the CRH O'Regan System, a single-use, disposable, hemorrhoid banding technology that is safe and highly effective in treating all grades of hemorrhoids. CRH distributes the O'Regan System, treatment protocols, operational and marketing exper..." |
|
12/14/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data
Docs:
|
"SECURITIES AND EXCHANGE COMMISSION",
"FDHS Transaction Highlights: Estimated annual revenue of US $3.0 million EBITDA and cash flow accretive Dr. Tushar Ramani, CEO of CRH, commented on the transaction, "The acquisition of FDHS represents our sixth anesthesia acquisition since June, and deepens our presence in Florida. We look forward to working with our FDHS partners to deliver a superior patient experience." Jay Kreger, President of CRH Anesthesia, added, "We are now providing anesthesia services to 11 ambulatory surgery centers in Florida, representing our largest footprint within the 13 states where we have a presence. We are encouraged by our business development pipeline, with numerous opportunities to expand our anesthesia platform in 2021 and beyond." About CRH Medical Corporation: CRH Medical Corporation is a North Am..." |
|
11/05/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data
Docs:
|
"SECURITIES AND EXCHANGE COMMISSION",
"CRH Medical Corporation to Announce 2020 Third Quarter Results on November 12, 2020 VANCOUVER, BC, Nov. 5, 2020 /CNW/ - CRH Medical Corporation , plans to release its results for the quarter ended September 30, 2020, on Thursday, November 12, 2020 after market close. The Company's executive management will discuss the results during a conference call on Friday, November 13, 2020 at 8:30 am Eastern Time/5:30 am Pacific Time. To participate in the call, please dial 1-888-664-6392 or 1-416-764-8659 and reference confirmation # 64836562. An audio replay will be available shortly after the call by dialing 1-888-390-0541 or 1-416-764-8677 and entering access code 836562#. The replay will be available for two weeks after the call. About CRH Medical Corporation:" |
|
10/09/2020 |
8-K/A
| Quarterly results |
10/09/2020 |
8-K/A
| Quarterly results |
10/06/2020 |
8-K
| Quarterly results |
09/01/2020 |
8-K
| Quarterly results |
08/10/2020 |
8-K
| Quarterly results |
08/04/2020 |
8-K
| Quarterly results |
08/03/2020 |
8-K
| Quarterly results |
07/07/2020 |
8-K
| Quarterly results |
06/22/2020 |
8-K
| Quarterly results |
06/12/2020 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits |
06/08/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
05/12/2020 |
8-K
| Quarterly results |
05/04/2020 |
8-K
| Quarterly results |
04/28/2020 |
8-K/A
| Appointed a new director |
04/23/2020 |
8-K
| Appointed a new director |
04/17/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
03/23/2020 |
8-K/A
| Quarterly results |
03/19/2020 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
03/11/2020 |
8-K
| Quarterly results |
|
|
|